FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2100029575> ?p ?o ?g. }

• W2100029575 abstract "Knowledge on immunosuppressive factors in the pathogenesis of endometrial cancer is scarce. The aim of this study was to assess Glycodelin (Gd) and its immunosuppressive isoform Glycodelin A (GdA) in endometrial cancer tissue and to analyze its impact on clinical and pathological features and patient outcome. 292 patients diagnosed and treated for endometrial cancer were included. Patient characteristics, histology and follow-up data were available. Gd and GdA was determined by immunohistochemistry and in situ hybridization was performed for Gd mRNA. Endometrial cancer shows intermediate (52.2%) or high (20.6%) expression for Gd in 72.8%, and GdA in 71.6% (intermediate 62.6%, high 9.0%) of all cases. The glycosylation dependent staining of GdA is tumour specific and correlates with the peptide-specific Gd staining though neither of the two is associated with estrogen receptor, progesterone receptor or clinic-pathological features. Also Gd protein positively correlates with Gd mRNA as quantified by in situ hybridization. Gd positive cases have a favourable prognosis (p = 0.039), while GdA positive patients have a poor outcome (p = 0.003). Cox-regression analysis proofed GdA to be an independent prognostic marker for patient survival (p = 0.002), besides tumour stage, grade and the concomitant diagnosis of hypertension. Gd and GdA are commonly expressed in endometrial cancer tissue and seem to be of relevance in tumourigenesis. They differ not only in glycosylation but also in their biological activity, since only GdA holds prognostic significance for a poor overall survival in endometrial cancer patients. This finding might be explained by GdAs immunosuppressive capacity." @default.
• W2100029575 created "2016-06-24" @default.
• W2100029575 creator A5001735605 @default.
• W2100029575 creator A5012452041 @default.
• W2100029575 creator A5014424241 @default.
• W2100029575 creator A5024083609 @default.
• W2100029575 creator A5035590576 @default.
• W2100029575 creator A5042962618 @default.
• W2100029575 creator A5044467977 @default.
• W2100029575 creator A5050124544 @default.
• W2100029575 creator A5083705585 @default.
• W2100029575 date "2013-12-01" @default.
• W2100029575 modified "2023-10-10" @default.
• W2100029575 title "Immunosuppressive Glycodelin A is an independent marker for poor prognosis in endometrial cancer" @default.
• W2100029575 cites W1582201599 @default.
• W2100029575 cites W1702834810 @default.
• W2100029575 cites W1967334830 @default.
• W2100029575 cites W1970262192 @default.
• W2100029575 cites W1973718753 @default.
• W2100029575 cites W1978281808 @default.
• W2100029575 cites W1982788039 @default.
• W2100029575 cites W1986840948 @default.
• W2100029575 cites W1987333228 @default.
• W2100029575 cites W1990612902 @default.
• W2100029575 cites W1999516495 @default.
• W2100029575 cites W2001640011 @default.
• W2100029575 cites W2009142138 @default.
• W2100029575 cites W2009233168 @default.
• W2100029575 cites W2017341185 @default.
• W2100029575 cites W2024428875 @default.
• W2100029575 cites W2031645150 @default.
• W2100029575 cites W2037175180 @default.
• W2100029575 cites W2037266386 @default.
• W2100029575 cites W2040197564 @default.
• W2100029575 cites W2044869180 @default.
• W2100029575 cites W2044983496 @default.
• W2100029575 cites W2050977656 @default.
• W2100029575 cites W2058004221 @default.
• W2100029575 cites W2060982818 @default.
• W2100029575 cites W2086024860 @default.
• W2100029575 cites W2088306386 @default.
• W2100029575 cites W2091785704 @default.
• W2100029575 cites W2100193535 @default.
• W2100029575 cites W2108662489 @default.
• W2100029575 cites W2113780740 @default.
• W2100029575 cites W2124494811 @default.
• W2100029575 cites W2127456152 @default.
• W2100029575 cites W2128471006 @default.
• W2100029575 cites W2136080569 @default.
• W2100029575 cites W2141865164 @default.
• W2100029575 cites W2144536590 @default.
• W2100029575 cites W2155014807 @default.
• W2100029575 cites W2162093136 @default.
• W2100029575 cites W2171141282 @default.
• W2100029575 cites W2171806725 @default.
• W2100029575 cites W4254055538 @default.
• W2100029575 doi "https://doi.org/10.1186/1471-2407-13-616" @default.
• W2100029575 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3898404" @default.
• W2100029575 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24377825" @default.
• W2100029575 hasPublicationYear "2013" @default.
• W2100029575 type Work @default.
• W2100029575 sameAs 2100029575 @default.
• W2100029575 citedByCount "20" @default.
• W2100029575 countsByYear W21000295752015 @default.
• W2100029575 countsByYear W21000295752017 @default.
• W2100029575 countsByYear W21000295752018 @default.
• W2100029575 countsByYear W21000295752019 @default.
• W2100029575 countsByYear W21000295752020 @default.
• W2100029575 countsByYear W21000295752021 @default.
• W2100029575 countsByYear W21000295752022 @default.
• W2100029575 countsByYear W21000295752023 @default.
• W2100029575 crossrefType "journal-article" @default.
• W2100029575 hasAuthorship W2100029575A5001735605 @default.
• W2100029575 hasAuthorship W2100029575A5012452041 @default.
• W2100029575 hasAuthorship W2100029575A5014424241 @default.
• W2100029575 hasAuthorship W2100029575A5024083609 @default.
• W2100029575 hasAuthorship W2100029575A5035590576 @default.
• W2100029575 hasAuthorship W2100029575A5042962618 @default.
• W2100029575 hasAuthorship W2100029575A5044467977 @default.
• W2100029575 hasAuthorship W2100029575A5050124544 @default.
• W2100029575 hasAuthorship W2100029575A5083705585 @default.
• W2100029575 hasBestOaLocation W21000295751 @default.
• W2100029575 hasConcept C104317684 @default.
• W2100029575 hasConcept C105580179 @default.
• W2100029575 hasConcept C121608353 @default.
• W2100029575 hasConcept C126322002 @default.
• W2100029575 hasConcept C142724271 @default.
• W2100029575 hasConcept C143998085 @default.
• W2100029575 hasConcept C146357865 @default.
• W2100029575 hasConcept C151730666 @default.
• W2100029575 hasConcept C204232928 @default.
• W2100029575 hasConcept C207886595 @default.
• W2100029575 hasConcept C2777088508 @default.
• W2100029575 hasConcept C2780140570 @default.
• W2100029575 hasConcept C50382708 @default.
• W2100029575 hasConcept C55493867 @default.
• W2100029575 hasConcept C63363279 @default.
• W2100029575 hasConcept C71924100 @default.
• W2100029575 hasConcept C81439078 @default.
• W2100029575 hasConcept C86803240 @default.

• next